Genpact Free Cash Flow Yield vs Capex To Revenue Analysis

G Stock

USD 46.19 0.37 0.81%

Genpact financial indicator trend analysis is much more than just examining Genpact Limited latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Genpact Limited is a good investment. Please check the relationship between Genpact Free Cash Flow Yield and its Capex To Revenue accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genpact Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Free Cash Flow Yield vs Capex To Revenue

Free Cash Flow Yield vs Capex To Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Genpact Limited Free Cash Flow Yield account and Capex To Revenue. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Genpact's Free Cash Flow Yield and Capex To Revenue is -0.28. Overlapping area represents the amount of variation of Free Cash Flow Yield that can explain the historical movement of Capex To Revenue in the same time period over historical financial statements of Genpact Limited, assuming nothing else is changed. The correlation between historical values of Genpact's Free Cash Flow Yield and Capex To Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow Yield of Genpact Limited are associated (or correlated) with its Capex To Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Revenue has no effect on the direction of Free Cash Flow Yield i.e., Genpact's Free Cash Flow Yield and Capex To Revenue go up and down completely randomly.

Correlation Coefficient

-0.28

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Free Cash Flow Yield

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Most indicators from Genpact's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Genpact Limited current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genpact Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

At this time, Genpact's Enterprise Value Multiple is most likely to slightly decrease in the upcoming years.

	2021	2022	2023	2024 (projected)
Gross Profit	1.4B	1.5B	1.6B	902.8M
Total Revenue	4.0B	4.4B	4.5B	2.4B

Gross Profit Total Revenue

Genpact fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Other Assets	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Net Receivables	Good Will	Common Stock Total Equity	Non Current Liabilities Total	Inventory
Total Assets		0.94	0.86	0.65	0.85	0.44	0.85	0.34	0.93	0.98	0.97	0.95	0.97	0.95	0.67	0.84	0.91	0.52	0.97	0.86	0.87	0.96	0.99	-0.72	0.91	-0.07
Total Stockholder Equity	0.94		0.7	0.76	0.83	0.19	0.83	0.48	0.96	0.87	0.96	0.79	0.9	0.91	0.77	0.71	0.79	0.52	0.87	0.8	0.67	0.93	0.9	-0.8	0.74	-0.21
Net Debt	0.86	0.7		0.6	0.55	0.5	0.56	0.01	0.7	0.9	0.75	0.93	0.89	0.83	0.32	0.87	0.8	0.47	0.92	0.79	0.89	0.85	0.9	-0.44	0.91	-0.16
Retained Earnings	0.65	0.76	0.6		0.53	-0.09	0.55	0.18	0.63	0.57	0.63	0.52	0.61	0.67	0.53	0.6	0.57	0.42	0.66	0.58	0.36	0.67	0.64	-0.43	0.46	-0.7
Cash	0.85	0.83	0.55	0.53		0.39	1.0	0.52	0.83	0.82	0.9	0.75	0.75	0.77	0.81	0.63	0.86	0.32	0.75	0.64	0.7	0.73	0.79	-0.72	0.75	0.09
Other Assets	0.44	0.19	0.5	-0.09	0.39		0.38	-0.16	0.2	0.56	0.32	0.62	0.42	0.42	0.09	0.59	0.57	0.0	0.53	0.34	0.62	0.3	0.47	-0.04	0.62	0.38
Cash And Short Term Investments	0.85	0.83	0.56	0.55	1.0	0.38		0.52	0.83	0.81	0.9	0.75	0.75	0.77	0.81	0.63	0.86	0.33	0.75	0.64	0.7	0.73	0.79	-0.72	0.75	0.07
Common Stock Shares Outstanding	0.34	0.48	0.01	0.18	0.52	-0.16	0.52		0.59	0.25	0.5	0.11	0.3	0.17	0.74	0.02	0.18	0.14	0.12	0.1	0.18	0.25	0.21	-0.88	0.18	0.37
Other Stockholder Equity	0.93	0.96	0.7	0.63	0.83	0.2	0.83	0.59		0.88	0.98	0.8	0.92	0.86	0.74	0.63	0.79	0.53	0.82	0.82	0.75	0.92	0.89	-0.89	0.78	-0.02
Total Liab	0.98	0.87	0.9	0.57	0.82	0.56	0.81	0.25	0.88		0.93	0.99	0.97	0.93	0.59	0.87	0.93	0.5	0.98	0.86	0.93	0.94	0.98	-0.64	0.97	0.01
Total Current Assets	0.97	0.96	0.75	0.63	0.9	0.32	0.9	0.5	0.98	0.93		0.87	0.94	0.9	0.76	0.72	0.88	0.51	0.89	0.84	0.81	0.94	0.94	-0.82	0.85	-0.01
Short Long Term Debt Total	0.95	0.79	0.93	0.52	0.75	0.62	0.75	0.11	0.8	0.99	0.87		0.94	0.9	0.48	0.9	0.92	0.47	0.98	0.84	0.95	0.91	0.97	-0.52	0.98	0.0
Other Current Liab	0.97	0.9	0.89	0.61	0.75	0.42	0.75	0.3	0.92	0.97	0.94	0.94		0.93	0.54	0.8	0.86	0.51	0.95	0.89	0.89	0.97	0.98	-0.7	0.91	-0.06
Total Current Liabilities	0.95	0.91	0.83	0.67	0.77	0.42	0.77	0.17	0.86	0.93	0.9	0.9	0.93		0.57	0.78	0.85	0.57	0.95	0.91	0.76	0.94	0.97	-0.59	0.8	-0.23
Other Liab	0.67	0.77	0.32	0.53	0.81	0.09	0.81	0.74	0.74	0.59	0.76	0.48	0.54	0.57		0.46	0.56	0.38	0.53	0.39	0.4	0.55	0.57	-0.79	0.5	0.06
Property Plant And Equipment Net	0.84	0.71	0.87	0.6	0.63	0.59	0.63	0.02	0.63	0.87	0.72	0.9	0.8	0.78	0.46		0.8	0.29	0.92	0.62	0.8	0.78	0.84	-0.36	0.89	-0.16
Current Deferred Revenue	0.91	0.79	0.8	0.57	0.86	0.57	0.86	0.18	0.79	0.93	0.88	0.92	0.86	0.85	0.56	0.8		0.38	0.9	0.84	0.87	0.85	0.9	-0.52	0.91	-0.04
Accounts Payable	0.52	0.52	0.47	0.42	0.32	0.0	0.33	0.14	0.53	0.5	0.51	0.47	0.51	0.57	0.38	0.29	0.38		0.5	0.62	0.4	0.58	0.57	-0.4	0.41	-0.23
Non Current Assets Total	0.97	0.87	0.92	0.66	0.75	0.53	0.75	0.12	0.82	0.98	0.89	0.98	0.95	0.95	0.53	0.92	0.9	0.5		0.86	0.87	0.94	0.98	-0.53	0.93	-0.17
Non Currrent Assets Other	0.86	0.8	0.79	0.58	0.64	0.34	0.64	0.1	0.82	0.86	0.84	0.84	0.89	0.91	0.39	0.62	0.84	0.62	0.86		0.76	0.92	0.91	-0.54	0.76	-0.23
Long Term Debt	0.87	0.67	0.89	0.36	0.7	0.62	0.7	0.18	0.75	0.93	0.81	0.95	0.89	0.76	0.4	0.8	0.87	0.4	0.87	0.76		0.83	0.88	-0.53	0.98	0.21
Net Receivables	0.96	0.93	0.85	0.67	0.73	0.3	0.73	0.25	0.92	0.94	0.94	0.91	0.97	0.94	0.55	0.78	0.85	0.58	0.94	0.92	0.83		0.97	-0.66	0.86	-0.18
Good Will	0.99	0.9	0.9	0.64	0.79	0.47	0.79	0.21	0.89	0.98	0.94	0.97	0.98	0.97	0.57	0.84	0.9	0.57	0.98	0.91	0.88	0.97		-0.63	0.92	-0.12
Common Stock Total Equity	-0.72	-0.8	-0.44	-0.43	-0.72	-0.04	-0.72	-0.88	-0.89	-0.64	-0.82	-0.52	-0.7	-0.59	-0.79	-0.36	-0.52	-0.4	-0.53	-0.54	-0.53	-0.66	-0.63		-0.54	-0.2
Non Current Liabilities Total	0.91	0.74	0.91	0.46	0.75	0.62	0.75	0.18	0.78	0.97	0.85	0.98	0.91	0.8	0.5	0.89	0.91	0.41	0.93	0.76	0.98	0.86	0.92	-0.54		0.11
Inventory	-0.07	-0.21	-0.16	-0.7	0.09	0.38	0.07	0.37	-0.02	0.01	-0.01	0.0	-0.06	-0.23	0.06	-0.16	-0.04	-0.23	-0.17	-0.23	0.21	-0.18	-0.12	-0.2	0.11

Click cells to compare fundamentals

Genpact Account Relationship Matchups

Genpact fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	4.5B	4.9B	5.0B	4.6B	4.8B	3.1B
Total Stockholder Equity	1.7B	1.8B	1.9B	1.8B	2.2B	1.4B
Net Debt	1.3B	1.3B	1.1B	1.0B	919.3M	965.3M
Retained Earnings	648.7M	741.7M	732.5M	780.0M	1.1B	1.1B
Cash	467.1M	680.4M	899.5M	646.8M	583.7M	449.6M
Other Assets	478.8M	961.1M	667.3M	439.6M	1.0	0.95
Cash And Short Term Investments	467.1M	680.4M	899.5M	646.8M	583.7M	472.7M
Common Stock Shares Outstanding	195.2M	195.8M	193.0M	188.1M	185.1M	200.1M
Liabilities And Stockholders Equity	4.5B	4.9B	5.0B	4.6B	4.8B	3.1B
Other Stockholder Equity	1.6B	1.6B	1.7B	1.8B	1.9B	1.3B
Total Liab	2.8B	3.0B	3.1B	2.8B	2.6B	1.6B
Total Current Assets	1.6B	1.7B	1.9B	1.8B	1.9B	1.2B
Short Long Term Debt Total	1.8B	1.9B	2.0B	1.7B	1.5B	950.6M
Other Current Liab	629.7M	634.0M	612.3M	614.8M	635.9M	457.9M
Total Current Liabilities	910.2M	1.2B	1.3B	1.1B	1.3B	758.6M
Other Liab	192.2M	239.9M	249.2M	208.0M	239.2M	192.5M
Property Plant And Equipment Net	584.9M	535.8M	485.7M	379.1M	393.7M	285.6M
Current Deferred Revenue	97.3M	154.7M	160.6M	160.6M	112.4M	77.9M
Accounts Payable	22.0M	13.9M	25.0M	35.8M	27.7M	20.2M
Non Current Assets Total	2.9B	3.1B	3.1B	2.8B	2.9B	1.9B
Non Currrent Assets Other	217.1M	323.8M	322.2M	450.5M	384.0M	213.2M
Long Term Debt	1.3B	1.3B	1.3B	1.2B	824.7M	690.1M
Net Receivables	914.3M	892.7M	899.0M	1.0B	1.1B	615.0M
Good Will	1.6B	1.7B	1.7B	1.7B	1.7B	1.2B
Common Stock Total Equity	1.9M	1.9M	1.8M	1.8M	1.6M	2.6M
Non Current Liabilities Total	1.9B	1.8B	1.8B	1.7B	1.2B	966.8M
Inventory	121.2M	150.1M	103.7M	1.0	(137.5M)	(130.6M)
Other Current Assets	49.2M	175.7M	123.1M	123.1M	174.1M	182.8M
Property Plant And Equipment Gross	618.4M	585.9M	485.7M	379.1M	984.1M	1.0B
Accumulated Other Comprehensive Income	(532.0M)	(545.3M)	(554.4M)	(733.1M)	(722.6M)	(686.4M)
Short Term Debt	161.2M	358.1M	463.6M	246.8M	503.4M	528.6M
Intangible Assets	230.9M	236.7M	169.6M	89.7M	53.0M	50.4M
Common Stock	1.9M	1.9M	1.8M	1.8M	1.8M	2.5M
Property Plant Equipment	254.0M	231.1M	485.7M	379.1M	436.0M	238.5M
Short Term Investments	1.8M	8.8M	5.8M	5.4M	4.4M	4.2M
Net Tangible Assets	(116.2M)	(98.2M)	(3.5M)	52.2M	47.0M	44.7M

Currently Active Assets on Macroaxis

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America
S	SentinelOne
WD	Walker Dunlop

How To Invest In Genpact

Details

Is Genpact Stock a good investment?

Details

What is Genpact's Net Worth?

Details

Largest Data Processing & Outsourced Services Companies

View

Largest Commercial & Professional Services Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genpact Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Is Data Processing & Outsourced Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genpact. If investors know Genpact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genpact listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.156

Dividend Share

0.595

Earnings Share

3.64

Revenue Per Share

25.964

Quarterly Revenue Growth

0.066

The market value of Genpact Limited is measured differently than its book value, which is the value of Genpact that is recorded on the company's balance sheet. Investors also form their own opinion of Genpact's value that differs from its market value or its book value, called intrinsic value, which is Genpact's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genpact's market value can be influenced by many factors that don't directly affect Genpact's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Genpact's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genpact is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genpact's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Genpact Free Cash Flow Yield vs Capex To Revenue Analysis

Free Cash Flow Yield vs Capex To Revenue

Free Cash Flow Yield vs Capex To Revenue Correlation Analysis

Correlation Coefficient

Free Cash Flow Yield

Capex To Revenue

Genpact fundamental ratios Correlations

Genpact Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Genpact fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Good Will	+ 0.99	Total Assets
Short Long Term Debt Total	+ 0.99	Total Liab
Total Liab	+ 0.98	Total Assets
Total Current Assets	+ 0.98	Other Stockholder Equity
Non Current Assets Total	+ 0.98	Total Liab

Common Stock Total Equity	- 0.89	Other Stockholder Equity
Common Stock Total Equity	- 0.88	Common Stock Shares Outstanding
Common Stock Total Equity	- 0.82	Total Current Assets
Common Stock Total Equity	- 0.8	Total Stockholder Equity
Common Stock Total Equity	- 0.79	Other Liab
Common Stock Total Equity	- 0.72	Cash And Short Term Investments